GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Acro Biomedical Co Ltd (OTCPK:ACBM) » Definitions » EBITDA Margin %

Acro Biomedical Co (Acro Biomedical Co) EBITDA Margin % : 0.00% (As of Jun. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Acro Biomedical Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Acro Biomedical Co's EBITDA for the three months ended in Jun. 2023 was $-3.20 Mil. Acro Biomedical Co's Revenue for the three months ended in Jun. 2023 was $0.00 Mil. Therefore, Acro Biomedical Co's EBITDA margin for the quarter that ended in Jun. 2023 was 0.00%.


Acro Biomedical Co EBITDA Margin % Historical Data

The historical data trend for Acro Biomedical Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acro Biomedical Co EBITDA Margin % Chart

Acro Biomedical Co Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Dec20 Dec21 Dec22
EBITDA Margin %
Get a 7-Day Free Trial 6.44 -32.64 -18.90 -642.24 -2,408.19

Acro Biomedical Co Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -1,092.78 - -

Competitive Comparison of Acro Biomedical Co's EBITDA Margin %

For the Medical Distribution subindustry, Acro Biomedical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acro Biomedical Co's EBITDA Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Acro Biomedical Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Acro Biomedical Co's EBITDA Margin % falls into.



Acro Biomedical Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Acro Biomedical Co's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-15.87/0.659
=-2,408.19 %

Acro Biomedical Co's EBITDA Margin % for the quarter that ended in Jun. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-3.195/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acro Biomedical Co  (OTCPK:ACBM) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Acro Biomedical Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Acro Biomedical Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Acro Biomedical Co (Acro Biomedical Co) Business Description

Traded in Other Exchanges
N/A
Address
12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038
Acro Biomedical Co Ltd develops and manufactures nutritional products. The company offers cordyceps fungus for medicinal purposes. It also sells cordycepin and cordyceps powder.
Executives
Pao-chi Chu director, 10 percent owner, officer: CEO 2F, NO. 356 SEC 1. DUNHUA S. RD., DA'AN DISTRICT, TAIPEI CITY F5 106

Acro Biomedical Co (Acro Biomedical Co) Headlines

No Headlines